Cover Image

German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients

Show other versions (1)

177Lu-labeled PSMA-617 is a promising new therapeutic agent for radioligand therapy (RLT) of patients with metastatic castration-resistant prostate cancer (mCRPC). Initiated by the German Society of Nuclear Medicine, a retrospective multicenter data analysis was started in 2015 to evaluate efficacy...

Full description

Saved in:
Bibliographic Details
Main Authors: Rahbar, Kambiz (Author) , Kratochwil, Clemens (Author) , Haberkorn, Uwe (Author) , Krause, Bernd Joachim (Author)
Format: Article (Journal)
Language:English
Published: January 1, 2017
In: Journal of nuclear medicine
Year: 2017, Volume: 58, Issue: 1, Pages: 85-90
ISSN:2159-662X
DOI:10.2967/jnumed.116.183194
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.2967/jnumed.116.183194
Verlag, kostenfrei, Volltext: https://jnm.snmjournals.org/content/58/1/85
Verlag, Volltext: http://jnm.snmjournals.org/content/58/1/85
Verlag, Volltext: http://dx.doi.org/10.2967/jnumed.116.183194
Get full text
Author Notes:Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Uwe Haberkorn, Michael Schäfers, Markus Essler, Richard P. Baum, Harshad R. Kulkarni, Matthias Schmidt, Alexander Drzezga, Peter Bartenstein, Andreas Pfestroff, Markus Luster, Ulf Lützen, Marlies Marx, Vikas Prasad, Winfried Brenner, Alexander Heinzel, Felix M. Mottaghy, Juri Ruf, Philipp Tobias Meyer, Martin Heuschkel, Maria Eveslage, Martin Bögemann, Wolfgang Peter Fendler, and Bernd Joachim Krause
Search Result 1
Cover Image

German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients by Rahbar, Kambiz (Author) , Ahmadzadehfar, Hojjat (Author) , Kratochwil, Clemens (Author) , Haberkorn, Uwe (Author) , Heuschkel, Martin (Author) , Krause, Bernd Joachim (Author) ,


Get full text
Article (Journal)

Saved in:
Show all versions (2)

Similar Items